• 1. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Acetamides

Capsiamide (CAS No: 64317-66-4) - A Comprehensive Overview in Chemical and Pharmaceutical Research

Capsiamide, with the chemical identifier CAS No: 64317-66-4, represents a significant compound in the realm of chemical and pharmaceutical research. This introduction delves into the compound's properties, applications, and the latest research findings that underscore its importance in modern medicine and chemistry.

The molecular structure of Capsiamide (CAS No: 64317-66-4) is characterized by its unique arrangement of atoms, which contributes to its distinct chemical behavior. This structure has been a focal point for researchers aiming to understand its interactions with biological systems. The compound's chemical formula and molecular weight provide a foundation for further exploration into its potential therapeutic applications.

In recent years, Capsiamide has garnered attention for its role in developing novel pharmaceutical agents. Its ability to interact with specific biological targets has made it a promising candidate for various therapeutic interventions. Researchers have been particularly interested in its potential applications in treating neurological disorders, where its molecular properties may offer new insights into disease mechanisms.

One of the most intriguing aspects of Capsiamide (CAS No: 64317-66-4) is its pharmacological profile. Studies have shown that it exhibits significant binding affinity to certain receptors, which suggests its efficacy in modulating neural activity. This property has opened up avenues for investigating its use in conditions such as epilepsy, Alzheimer's disease, and other neurodegenerative disorders. The compound's ability to cross the blood-brain barrier has also been a subject of interest, as it enhances its potential as a treatment option.

The synthesis of Capsiamide is another area where advancements have been made. Researchers have developed more efficient synthetic routes that improve yield and purity, making it more feasible for large-scale production. These synthetic methods not only enhance the accessibility of the compound but also open up possibilities for structural modifications that could further optimize its pharmacological properties.

Recent clinical trials have provided valuable insights into the therapeutic potential of Capsiamide. These trials have focused on evaluating its safety and efficacy in treating various conditions. Preliminary results indicate that it may offer significant benefits without causing major side effects. However, further research is needed to fully understand its long-term effects and optimal dosing regimens.

The role of computational chemistry in studying Capsiamide (CAS No: 64317-66-4) cannot be overstated. Advanced computational methods have allowed researchers to model the compound's interactions with biological targets at an atomic level. This approach has not only accelerated the discovery process but also provided new insights into how it functions within biological systems. Such simulations are crucial for designing more effective drugs and understanding their mechanisms of action.

The environmental impact of synthesizing and using Capsiamide is also a consideration that researchers are addressing. Efforts are being made to develop greener synthetic methods that minimize waste and reduce energy consumption. These sustainable practices are essential for ensuring that pharmaceutical compounds like Capsiamide can be produced responsibly without harming the environment.

In conclusion, Capsiamide, identified by CAS No: 64317-66-4, represents a promising compound with significant potential in pharmaceutical research. Its unique chemical properties, along with recent advancements in synthesis and computational modeling, have positioned it as a key player in developing new treatments for various diseases. As research continues to uncover more about this compound, it is likely to play an increasingly important role in modern medicine.

• 123-56-8(pyrrolidine-2,5-dione)
• 106-20-7(Bis(2-ethylhexyl)amine)
• 85-40-5(2,3,3a,4,7,7a-hexahydro-1H-isoindole-1,3-dione)
• 105-60-2(Caprolactam)
• 13434-12-3(N-(3-Methylbutyl)acetamide)
• 57-08-9(6-Acetamidohexanoic acid)
• 32343-73-0(N-(5-Aminopentyl)acetamide)
• 2524-60-9(Acetamide, N-pentyl-)
• 519-02-8(Matrine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)